IDiyas

For the Inventor, By the Inventor

Maple Grove, MN, United States of America

David C Ullestad

USPTO Granted Patents = 14 

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 429(Granted Patents)


Company Filing History:

goldMedal14 out of 8,729 
 
Medtronic, Inc.
 patents

Years Active: 2001-2024

Loading Chart...
14 patents (USPTO):Explore Patents
1. 11883669 - Therapy adjustment (2024-01-30),
2. 11154717 - Therapy adjustment based on patient event indication (2021-10-26),
3. 10561845 - Therapy adjustment based on patient event indication (2020-02-18),
4. 9529972 - Patient event indication (2016-12-27),
5. 8612055 - System and method for delivering a therapeutic agent according to default infusion schedule (2013-12-17),
6. 8562591 - Drug infusion system and method adapted to start during programming cycle (2013-10-22),
7. 8326431 - Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore (2012-12-04),
8. 8282625 - Implantable medical device with time for therapeutic output replenishment determination and method therefore (2012-10-09),
9. 8241270 - Drug infusion system and method adapted to start during programming cycle (2012-08-14),
10. 7160284 - Implantable medical pump with multi-layer back-up memory (2007-01-09),
11. 7008413 - Generic multi-step therapeutic treatment protocol (2006-03-07),
12. 6635048 - Implantable medical pump with multi-layer back-up memory (2003-10-21),
13. 6579280 - Generic multi-step therapeutic treatment protocol (2003-06-17),
14. 6282450 - System and method for storing firmware in a human-implantable medical treatment device (2001-08-28),

Title: The Innovations of David C Ullestad

Introduction

David C Ullestad is a notable inventor based in Maple Grove, MN (US), recognized for his contributions to medical technology. He holds a total of 14 patents, showcasing his innovative spirit and dedication to improving patient care through advanced therapy solutions.

Latest Patents

Among his latest patents is a groundbreaking invention focused on therapy adjustment. This patent outlines a method where an indication that a patient event has occurred can be utilized to evaluate the efficacy of at least one therapy program and adjust therapy delivery accordingly. The patient event indication may include input received via an event indication button on a programming device. Additionally, therapy delivery can be modified by adjusting therapy parameter values, switching therapy programs or groups, or restarting a therapy cycle of a medical device. Another patent emphasizes therapy adjustment based on patient event indications, reinforcing the importance of patient feedback in optimizing therapy outcomes.

Career Highlights

David Ullestad is currently employed at Medtronic, Inc., a leading company in medical technology. His work at Medtronic has allowed him to develop innovative solutions that enhance the effectiveness of therapy programs for patients.

Collaborations

Throughout his career, Ullestad has collaborated with talented individuals such as Irfan Z Ali and Peter Joseph Kovach. These partnerships have contributed to the advancement of medical technologies and the development of effective therapy solutions.

Conclusion

David C Ullestad's contributions to the field of medical technology through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to therapy adjustment demonstrate the potential for technology to enhance treatment efficacy and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…